OVERVIEW
The global market for viral clearance is projected to hit USD 1,576 million by 2025, growing over the forecast period at a CAGR of 20.12 per cent. This market’s growth is driven primarily by factors such as growth in the pharmaceutical and biotechnology industries, growing number of new product launches, life science R&D investments, developments in nanofiltration technology, and high incidence and high economic burden of chronic diseases.
TABLE OF CONTENT
1 Global Viral Clearance Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Viral Clearance Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global Viral Clearance Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Viral Clearance Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Viral Clearance Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Viral Clearance Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Viral Clearance Market – By Method (Market Size – & million/billion)
8.1 Viral Removal
8.2 Chromatography
8.3 Nanofiltration
8.4 Precipitation
8.5 Viral Inactivation
8.6 Low pH
8.7 Solvent Detergent Method
8.8 Pasteurization
8.9 Other
9 Global Viral Clearance Market – By Application
9.1 Recombinant Proteins
9.2 Blood and Blood Products
9.3 Vaccines
9.4 Other
10 Global Viral Clearance Market – By End-User
10.1 Pharmaceutical & Biotechnology Companies
10.2 Contract Research Organizations
10.3 Academic Research Institutes
10.4 Other
11 Global Viral Clearance Market – By Geography (Market Size – & million/billion)
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 U.K
11.3.2 Germany
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia-Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 South Korea
11.4.5 Rest of APAC
11.5 Rest of the World
11.5.1 South America
11.5.2 Middle East
11.5.3 Africa
12 Global Viral Clearance Market – Entropy
12.1 New product launches
12.2 M&A’s, collaborations, JVs and partnerships
13 Global Viral Clearance Market Company Profile (Key Players)
13.1 Market Share, Company Revenue, Products, M&A, Developments
13.2 Wuxi Biologics (Cayman) (Subsidiary of Wuxi Apptec)
13.3 Merck KGaA
13.4 Clean Cells
13.5 Bsl Bioservice
13.6 Virusure GmbH
13.7 Charles River Laboratories International
13.8 Texcell
13.9 Kedrion
13.10 Vironova Biosafety
13.11 Company 10
13.12 Company 11 & more
14 Global Viral Clearance Market – Appendix
14.1 Sources
14.2 Abbreviations